Session

Overview: In three separate presentations, this symposium will address aspects of Ocular Plaque Brachytherapy in current clinical practice. The speakers will discuss a range of topics in relation to I-125 and Ru-106 radioisotopes, from their clinical application in the treatment of ocular carcinomas, to their relative Clinical Quality Assurance and treatment planning requirements. Radiobiological relevance with regard to clinical management and resultant treatment outcomes will also be considered. The recent GEC-ESTRO Survey on Ocular Plaque Brachytherapy, which serves to evaluate clinical practice using Ru-106 plaques, will also be presented and analysed in this symposium.